Store

Home | Store | In Vitro Diagnostics Business Outlook, 2024

In Vitro Diagnostics Business Outlook, 2024

Publication Date: December 20, 2024

SKU: 24-014

Tags: Growth Rates, Immunoassay, In Vitro Diagnostics (IVD), Market Share, Market Size

Pages: Varies (average 30 pages)

SKU: 24-014

In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.

 

Key Features: 

  • Market data and forecasts: Gain access to growth rates, market size, market share, and more to identify growth opportunities in the IVD market. 
  • Comprehensive view of the IVD market: Explore various test categories covered and company briefs to stay informed about the latest developments in the industry. 
  • M&A activities and partnerships: Stay updated on mergers and acquisitions, selected partnerships, collaborations, and other deals shaping the IVD market landscape. 
  • Industry & region watch: Tailor your strategies with insights into industry trends and regional developments affecting the IVD market. 
  • Analysis of news and events: Get in-depth analysis of news and events impacting the IVD market, including reporting on news not easily available elsewhere. 

 

Publication Frequency:

Bimonthly (Six Issues Annually) 

 

Why Choose In Vitro Diagnostics Business Outlook, 2024: 

  • Exclusive market insights: Access information and data that you cannot find anywhere else, helping you stay ahead of the competition. 
  • Tailored strategies: Use the insights provided to tailor your business strategies and make informed decisions. 
  • Comprehensive coverage: Get a comprehensive view of the IVD market, including market data, company briefs, M&A activities, and industry news. 

 

Subscribe Now!

Don’t miss out on the valuable insights offered by In Vitro Diagnostics Business Outlook, 2024. Subscribe now to receive bimonthly issues and stay informed about the latest trends and developments in the IVD market. 

 

 

Table: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)

  2023  % Mkt  2028  % Mkt  CAGR 
Allergy  $XX Million  $XX Million  $XX Million  XX%  XX% 
Anemia  $XX Million  $XX Million  $XX Million  XX%  XX% 
Autoimmune  $XX Million  $XX Million  $XX Million  XX%  XX% 
Blood Bank Screening  $XX Million  $XX Million  $XX Million  XX%  XX% 
Cardiac Markers  $XX Million  $XX Million  $XX Million  XX%  XX% 
COVID-19  $XX Million  $XX Million  $XX Million  XX%  XX% 
Diabetes/HbA1c  $XX Million  $XX Million  $XX Million  XX%  XX% 
Fertility  $XX Million  $XX Million  $XX Million  XX%  XX% 
HAIs/Sepsis  $XX Million  $XX Million  $XX Million  XX%  XX% 
Hepatitis  $XX Million  $XX Million  $XX Million  XX%  XX% 
HIV  $XX Million  $XX Million  $XX Million  XX%  XX% 
Lyme disease  $XX Million  $XX Million  $XX Million  XX%  XX% 
Mycology  $XX Million  $XX Million  $XX Million  XX%  XX% 
Parasitology  $XX Million  $XX Million  $XX Million  XX%  XX% 
Proteins  $XX Million  $XX Million  $XX Million  XX%  XX% 
Respiratory (excl. COVID)  $XX Million  $XX Million  $XX Million  XX%  XX% 
STD  $XX Million  $XX Million  $XX Million  XX%  XX% 
Therapeutic Drugs  $XX Million  $XX Million  $XX Million  XX%  XX% 
Thyroid  $XX Million  $XX Million  $XX Million  XX%  XX% 
ToRCH  $XX Million  $XX Million  $XX Million  XX%  XX% 
Tox/Drug of Abuse  $XX Million  $XX Million  $XX Million  XX%  XX% 
Tumor Markers  $XX Million  $XX Million  $XX Million  XX%  XX% 
Vitamin D  $XX Million  $XX Million  $XX Million  XX%  XX% 
Other Infectious Disease  $XX Million  $XX Million  $XX Million  XX%  XX% 
Others Non-Infectious Disease  $XX Million  $XX Million  $XX Million  XX%  XX% 

Source: Kalorama Information 

For further details and to purchase directly, please contact us.

Table of Contents

Volume 3, Issue 1 – Focus on Molecular HLA Testing

Market Analysis: Molecular HLA/Transplant Testing

Overview of Molecular HLA/Transplant Testing

Market Outlook

Regional Market

Top Company Briefs

Immucor

Luminex/DiaSorin

CareDx

Thermo Fisher Scientific

Executive News Briefing

DEKFI Diagnostics Appoint New CEO

Onera Raises $32 Million in Funding

Cleveland Diagnostics Completes $75 Million in Funding

Financial Highlights: Agilent and Hologic

Agilent Full Year Fiscal 2023 Sales up 1.5% in Core Business YOY

  • Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
  • Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
  • Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
  • Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)

Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance

  • Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
  • Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
  • Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States,  All Others), FY 2023 (%)

Diagnostic Market Mergers, Acquisitions and Partnership Deals

Mergers and Acquisitions

  • Table: Selected Diagnostic Market Mergers and Acquisitions Deals

Partnerships and Collaborations

Industry Watch

COVID-19 Update

Region Watch

India

  • Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
  • Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)

Saudi Arabia

  • Figure: Saudi Arabia Population Pyramid, 2023 and 2053
  • Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
  • Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023

Broad-based Company Announcements

QuidelOrtho Obtains FDA Nod

Illumina Plans to Divest Grail

Roche to Acquire LumiraDx

QIAGEN Expands Footprint with New Regional Headquarters in Middle East

 

Volume 3, Issue 2 – Focus on Immunoassay Overview

Market Analysis

Overview of IVD Immunoassay

Market Outlook

  • Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
  • Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)

Regional Market

  • Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
  • Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)

Top Company Briefs

Roche

Abbott Diagnostics

Siemens Healthineers

Other Selected Immunoassay News

Executive News Briefing

NOWDiagnostics Selects New Science Officer

Freenome Raises $254 Million in New Funding

QuidelOrtho Axes CEO

Agilent CEO to Retire

Financial Highlights: Bio-Rad Laboratories and Veracyte

Bio-Rad Laboratories Reports Full-Year 2023 Clinical Diagnostics Revenues up 3.2% over previous year

  • Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
  • Figure: Bio-Rad Laboratories’ Sales by Business, 2022 vs. 2023, $M
  • Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
  • Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution

Veracyte Reported Strong Performance in 2023

  • Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD

Diagnostic Market Mergers, Acquisitions and Partnership Deals

Mergers and Acquisitions

  • Table: Selected Diagnostic Market Mergers and Acquisitions Deals

Partnerships and Collaborations

Industry Watch

Virus Testing Update

Region Watch

Peru

  • Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
  • Figure: Peru GDP Value and Growth by Year, 2010-2022
  • Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023

South Africa

  • Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
  • Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)

Broad-based Company Announcements

Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome

DiaSorin Nabs FDA Clearance for New LIAISON PLEX System

T2 Biosystems Offers Expanded Panel

Cepheid Received FDA Clearance for Xpert Xpress GBS

DiaCarta Collaboration to Launch Prostate Cancer LDT

 

Volume 3, Issue 3 – Clinical Chemistry

Market Analysis: Clinical Chemistry

Overview of Clinical Chemistry Market

Market Outlook

  • Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
  • Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)

Major Product Activity

  • Lab-based Clinical Chemistry
  • Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
  • Point-of-Care Clinical Chemistry
  • Table: Market Summary: POC-based Clinical Chemistry Market, 2023 and 2028 ($ millions)

Regional Market

  • Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ millions)
  • Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)

Top Company Briefs

Roche

Abbott

Danaher

Executive News Briefing

Cue Health Calls It Quits

Allenz Health Secures $60 Million in Funding

Next Gen Diagnostics Welcomes New Scientific Advisory Board Member

Next Gen Diagnostics Opens First U.S. Laboratory

Financial Highlights: bioMérieux & Sekisui Diagnostics

  • Figure: bioMérieux Sales Distribution, by Business Segment, 2023 (%)
  • Table: bioMérieux Financial Review, by Business Segment, FY 2022 – FY 2-23 (€M)
  • Figure: bioMérieux FY 2022 vs FY 2023 Regional Sales Breakdown (€M)
  • Table: Sekisui Chemical Financial Results, FY 2022 and FY 2023 (Billions of Yen)
  • Table: Sekisui Chemical Annual Overview and Focus, FY 2023 and FY 2024 (Billions of Yen)
  • Table: Sekisui Chemical Net Sales, by Segment, FY22 and FY23 (Billions of Yen)
  • Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 FY22 – Q4FY23 (Millions of Yen)

Diagnostic Market Mergers, Acquisitions and Partnership Deals

Mergers and Acquisitions

  • Table: Selected Diagnostic Market Mergers and Acquisitions Deals

Partnerships and Collaborations

Industry Watch

COVID-19/Flu Update

Region Watch

Japan

  • Figure: Japan National Health Expenditures, Year-on-Year Growth Rate, 1985-2019 (Yen trillion, %)
  • Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
  • Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds per Hospital, 2015-2019
  • Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
  • Figure: Japan IVD Market, by Segment, 2023 (%)

Broad-based Company Announcements

Announcements

QIAGEN Launches Gastrointestinal Molecular Panel in the United States

Illumina Spins Off Grail

QIAGEN Discontinues NeuMoDx  System

DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay

Genetic Signatures Granted FDA Clearance for GI Kit

Our Knowledge Center provides access to

all market reports